He He J J Zhang Zhang R R Shao Shao M M Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial Ann Rheum Dis Ann Rheum Dis 2020 2020 79 79 141 141 149 149 10.1136/annrheumdis-2019-215396 10.1136/annrheumdis-2019-215396 supplied-pmid 31537547? The gene discussed is IL2; the disease is systemic lupus erythematosus.